Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management
- 24 September 2007
- journal article
- review article
- Published by Wiley in Internal Medicine Journal
- Vol. 37 (10), 705-712
- https://doi.org/10.1111/j.1445-5994.2007.01479.x
Abstract
It is well known that immunosuppressive drugs or cancer chemotherapy can stimulate replication of hepatitis B virus (HBV) and precipitate severe flares of HBV infection. The risk of this syndrome of 'reactivation hepatitis B' is highest in haematopoietic stem cell or solid organ transplant recipients and in those undergoing chemotherapy for haematological malignancies; however, it has been described following almost any form of immunosuppressive treatment. Fortunately, it can be largely prevented by prophylactic therapy with oral anti-HBV nucleoside/nucleotide analogues. Importantly, chronic HBV infection is usually asymptomatic, and most patients at risk are likely to be unaware that they carry the infection. Thus, the key to avoiding this potentially fatal complication of immunosuppressive treatment is to ensure that all patients at risk of chronic HBV infection are screened for the disease before commencing immunosuppressive treatment or chemotherapy.Keywords
This publication has 76 references indexed in Scilit:
- Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patientsBreast Cancer Research and Treatment, 2004
- Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxisGut, 2004
- Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantationBone Marrow Transplantation, 2004
- Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host diseaseBone Marrow Transplantation, 2002
- Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivationBritish Journal of Haematology, 2000
- C ASE R EPORT: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapyJournal of Gastroenterology and Hepatology, 1999
- Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis BJournal of Hepatology, 1996
- Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapyJournal of Hepatology, 1989
- The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replicationJournal of Hepatology, 1986
- Effects of short‐term, high‐dose prednisone treatment of patients with HBsAg‐positive chronic active hepatitisLiver International, 1985